|
Core Support for Cancer Center
|
3P30CA013330-44S1
|
$199,871
|
$7,995
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S2
|
$199,989
|
$8,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
3P30CA013330-44S3
|
$500,000
|
$20,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Core Support for Cancer Center
|
5P30CA013330-44
|
$3,746,138
|
$149,846
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Par1-substrates responsible for CagA-mediated pathogenesis of Helicobacter pylori
|
5R01CA160790-06
|
$522,889
|
$522,889
|
MUESCH, ANNE
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-03
|
$1,033,213
|
$25,830
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Defining oncogenic capacities of PAK7 mutations in human cancer
|
5R21CA184656-02
|
$192,488
|
$48,122
|
HANSEN, STEEN
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Cancer Center Support Grant
|
3P30CA013696-42S1
|
$120,000
|
$1,200
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S2
|
$60,000
|
$600
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S3
|
$121,873
|
$1,219
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S4
|
$150,866
|
$1,509
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S5
|
$199,541
|
$1,995
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-42S6
|
$500,000
|
$5,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-42
|
$3,792,720
|
$37,927
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mouse Models of Gastric Cancer
|
5R01CA093405-14
|
$325,782
|
$325,782
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-03
|
$1,106,869
|
$27,672
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-03
|
$375,850
|
$4,698
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$8,142
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
An Integrated Approach to the Validation of Novel Gastric Cancer Oncogenes
|
4K08CA166512-05
|
$135,594
|
$135,594
|
NADAULD, LINCOLN
|
IHC HEALTH SERVICES, INC.
|
|
Building upon a tradition of excellence. The NCTN at Indiana University
|
5U10CA180795-03
|
$611,729
|
$6,117
|
MILLER, KATHY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Identification of novel spermine oxidase (SMOX) inhibitors as probes for an emerging chemoprevention target
|
1R01CA204345-01A1
|
$658,164
|
$329,082
|
CASERO, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S1
|
$60,000
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S2
|
$114,211
|
$1,142
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S3
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
4P30CA006973-53
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Large-scale Genetic Analyses of Human Cancer
|
4R01CA121113-10
|
$279,212
|
$13,961
|
VELCULESCU, VICTOR
|
JOHNS HOPKINS UNIVERSITY
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$147,135
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-03
|
$1,295,865
|
$12,959
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
$80,523
|
N/A
|
National Institutes of Health
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112-10339
|
$150,249
|
$60,100
|
Abnet, Christian
|
DCEG (NCI)
|
|
The Golestan Cohort Study
|
ZIA CP000185-10361
|
$137,842
|
$41,353
|
Abnet, Christian
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,193,520
|
$83,546
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
$39,573
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
$20,299
|
Barr, Frederic
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$371,569
|
$18,578
|
Bottaro, Donald
|
CCR (NCI)
|
|
Novel Tumor Suppressing Kinases in Cancer
|
ZIA BC 011690
|
$217,916
|
$2,179
|
Brognard, John
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$198,789
|
$3,976
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Cellular In vivo Imaging
|
ZIA BC 010657
|
$660,337
|
$66,034
|
Choyke, Peter
|
CCR (NCI)
|
|
Early Detection of Esophageal Cancer
|
ZIA CP000185-10317
|
$154,553
|
$23,183
|
Dawsey, Sanford
|
DCEG (NCI)
|
|
Gastric cancer: Randomized multi-intervention trial to inhibit precancerous gast
|
ZIA CP010182-00446
|
$24,388
|
$24,388
|
Gail, Mitchell
|
DCEG (NCI)
|
|
Transcription Regulation in E. coli and H. pylori
|
ZIA BC 010632
|
$644,227
|
$322,114
|
Jin, Ding
|
CCR (NCI)
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$7,069
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Integrated analyses of genetics, epigenetics, and gene expression
|
ZIH BC 011703
|
$669,766
|
$66,977
|
Lee, Maxwell
|
CCR (NCI)
|
|
Stomach cancer in Poland
|
ZIA CP010136-03140
|
$30,662
|
$30,662
|
Liao, Linda
|
DCEG (NCI)
|
|
Cancer risk in peptic ulcer patients
|
ZIA CP010131-04123
|
$1,922
|
$481
|
Little, Mark
|
DCEG (NCI)
|
|
Role of Shh in developmental patterning and growth of digit skeleton
|
ZIA BC 011118
|
$276,836
|
$27,684
|
Mackem, Susan
|
CCR (NCI)
|
|
Radiation dose- response and second primary cancers of stomach, esophagus, and p
|
ZIA CP010131-04134
|
$79,021
|
$15,804
|
Morton, Lindsay
|
DCEG (NCI)
|
|
Gastric cancer, infections & immunity
|
ZIA CP010212-10101
|
$96,410
|
$96,410
|
Rabkin, Charles
|
DCEG (NCI)
|
|
Shanghai prospective cohort study of occupational exposures and cancer risk among
|
ZIA CP010123-02342
|
$297,899
|
$163,845
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
Telomere length, cancer risk, and genetic determinants
|
ZIA CP010190-10371
|
$5,672
|
$567
|
Savage, Sharon
|
DCEG (NCI)
|
Total relevant funding to Stomach for this search: $13,286,733
|